SCNX Stock Catalyst: Scienture Holdings Announces Agreement to Expand REZENOPY™ Distribution

Sep 22, 2026 · 8:20am ET

Agreement targets approximately 2,000 addiction treatment centers.

Max move

+32.2%

High of day $0.39

Sparker timei

8:20am ET

SCNX · Sep 22, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Scienture Holdings, Inc. announced on September 22, 2026, an agreement with a distribution partner to expand the commercial reach of REZENOPY™ (naloxone hydrochloride nasal spray 10 mg/0.11 mL) to addiction treatment centers in the U.S.

The agreement involves the distribution of approximately 9.8 million units of REZENOPY™ to approximately 2,000 OTP (Opioid Treatment Program) clinics, with an estimated value of approximately $140 million.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time SCNX sparks.

Download Sniper App →

Catch the next SCNX-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →